Previous close | 5.50 |
Open | N/A |
Bid | 0.20 |
Ask | 1.20 |
Strike | 577.50 |
Expiry date | 2024-06-28 |
Day's range | 5.50 - 5.50 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.